´Ü±¹´ëÇб³º´¿ø 2018³â Á¦3Â÷ ´ëÇѺ´¸®ÇÐȸ ´ëÀü¤ýÃæûÁöȸ: ÃÖ½ÅÀÇÇÐÁ¤º¸ Ư° ¹× º´¸®ÇÐ Áõ·Ê ¹ßÇ¥ : 2018-09-06±³À°ÀÏÀÚ : 2018-09-06
±³À°Àå¼Ò : ´Ü±¹´ëÇб³º´¿ø 5Ãþ ¼¼¹Ì³ª½Ç
±³À°ÁÖÁ¦ :
2018³â Á¦3Â÷ ´ëÇѺ´¸®ÇÐȸ ´ëÀü¤ýÃæûÁöȸ: ÃÖ½ÅÀÇÇÐÁ¤º¸ Ư° ¹× º´¸®ÇÐ Áõ·Ê ¹ßÇ¥ ÁÖÃÖ±â°ü : ´ëÇѺ´¸®ÇÐȸ
´ã´çÀÚ : ´ëÇѺ´¸®ÇÐȸ
¿¬¶ôó : 02-795-3094
À̸ÞÀÏ :
kspjamoon@kams.or.kr ±³À°Á¾·ù : º´¸®°ú
Âü¼®¿¹»óÀοø : 30¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
Ãæû³²µµ±³À°½Ã°£ : 2 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 06ÀÏ ´Ü±¹´ëÇб³º´¿ø 5Ãþ ¼¼¹Ì³ª½Ç 18:00~18:30 °ÀÇ: Differential Protein Stability and Treatment Outcomes of EML4-ALK Fusion Variants to ALK Inhibitors and Hsp90 inhibitor in Advanced ALK-Rearranged Non-Small Cell Lung Cancer ¿ìâ°î(ÃæºÏ´ëÇб³º´¿ø)
±³À°½Ã°£ 09¿ù 06ÀÏ ´Ü±¹´ëÇб³º´¿ø 5Ãþ ¼¼¹Ì³ª½Ç 18:30~20:00 2. º´¸® ½½¶óÀ̵å Áý´ãȸ: Áõ·Ê ¹ßÇ¥ °íÀçÇâ(ÃæºÏ´ëÇб³º´¿ø)